Location: Home
  • search
  • go
  • Relate News
  • 6/2/2022NMPA Solicits Comments on the Draft Good Manufacturing Practices for D...
  • 6/2/2022China to Initiate Nationwide Unannounced BMI Fund Inspection
  • 6/2/2022Zelixir Biotech Looks to Help Global Monkeypox Drug Development
  • 6/1/2022Xuanzhu and CTTQ-Akeso Tie Up to Develop Penpulimab for Solid Tumors
  • 5/31/2022Recent Executive Moves
  • 5/30/2022SMEI: Review of Chinese Retail Pharmacy Market (Offline and Online)
  • 5/27/2022NMPA Issues Chinese GMP's Clinical Trial Drug Appendix
  • 5/26/2022Henlius and Abbott Enter Semi-Exclusive License Deal for Rituximab and...
  • 5/26/2022Data Snapshot: Top 20 Domestic Class 1 New Drugs by Sales in 2021
  • 5/26/2022April Licensing Trends Show Chinese Biotechs Expanding Beyond Oncology...
  • 5/26/2022Ten Trends of China's Pharmaceutical Industry in 2021 (PharmCube)
  • 5/25/2022Hanmi Launches High-blood Pressure Drug Meiyaping (Amosartan) in China
  • 5/25/2022State Council Issues Notice on Major Tasks for Deepening Healthcare Re...
  • 5/24/2022Vir and WuXi Bio Terminate COVID Antibody Agreement
  • 5/24/2022ImaginAb and Yantai DongCheng Enter License Deal to Commercialize CD8...
  • 5/24/2022CASI and Tianshi Enter Sublicense Deal for Anti-Cd38 mAb CID-103 in Au...
  • 5/23/2022Fujifilm Completes Construction of Bioprocessing Innovation & Collabor...
  • 5/23/2022Novartis's Promacta Approved in China for Expanded Use in Children Ag...
  • 5/23/2022Sinohealth: Chinese Hospital Drug Sales Fell 4% in Q1/2022
  • 5/23/2022IQVIA: Chinese Hospital Drug Market Rose 4.2% in Q1/2021
  • 5/23/2022VerImmune and Fosun Pharma Enter Licensing Deal for Virus-inspired Pa...
  • 5/23/2022Biopharma in China: The Emerging Global Force of Domestic Suppliers
  • 5/20/2022U.S., European Firms Rethink China Investment After Lockdowns
  • 5/20/2022VerImmune and Fosun in Deal for VerImmune's ViP Platform as Novel Im...
  • 5/20/2022Recent Executive Moves
  • 5/19/2022China Approves Bayer/MSD's Verquvo (vericiguat) for Chronic Heart Fail...
  • 5/19/2022CTTQ and Symphogen Enter Pact for Global Rights of Latter's mAb Sym022
  • 5/19/2022APAC Hospital Priorities 2022: Strategic Implications for Pharma Compa...
  • 5/19/2022Pediatric Drug Development A New Investment Area in China (PharmaDJ's ...
  • 5/17/2022SMEI: Chinese Public Medical Institution Drug Sales Surged 7.2% in 202...
  • Page:70/360 Total number of articles:10791: [First][<<] [68] [69] [70] [71] [72] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group